CA2824526C — Pegylated lipids and their use for drug delivery
Assigned to Alnylam Pharmaceuticals Inc · Expires 2020-07-07 · 6y expired
What this patent protects
The present invention relates to PEGylated lipids such as the chemical of formula I noted below and their use in formulations for delivering active agents, such as siRNA and microRNA: (see above formula)
USPTO Abstract
The present invention relates to PEGylated lipids such as the chemical of formula I noted below and their use in formulations for delivering active agents, such as siRNA and microRNA: (see above formula)
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.